Oxford Medical Diagnostics Ltd – New Breath Tests
The latest spin-out company from Oxford University, Oxford Medical Diagnostics Ltd, hopes to develop a way of diagnosing disease simply by testing someone's breath.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
The latest spin-out company from Oxford University, Oxford Medical Diagnostics Ltd, hopes to develop a way of diagnosing disease simply by testing someone's breath.
In a move to exploit its innovative location monitoring technology, OxLoc Ltd have announced the signing of a Memorandum of Understanding with Reliance Monitoring Services, a member of the Reliance Security Group plc.
Isis' latest spin-out company, ReOx Ltd, is set to develop potential therapies for a huge range of diseases, from heart disease to stroke, using world-leading expertise in biology and chemistry. The company was spun out this summer and has raised £2 million in capital investment.
OxLoc Ltd, a spin-out company from the University of Oxford, has announced their first successful pilot study within the rail freight industry.
A new product concept in UV protection and anti-ageing for sunscreens and cosmetics
NaturalMotion Ltd, which combines biology with computer science to create realistic and interactive character animation for games, films and simulations, has been launched as Oxford University's newest spin-out company.
Oxford ArchDigital Archaeology, a spin-out company from the University of Oxford, has been chosen to deliver the new Finds Management Software for the Portable Antiquities Scheme.
Oxford Business Alumni News Bulletin.
VASTox Ltd, Isis' first spin-out company of 2003, was launched in February from the University of Oxford's Chemistry Department.
Oxford University's latest spin-out is the drug-discovery company InhibOx Ltd, which uses advanced computational methods to carry out in silico screening on a massive scale to discover new leads for drugs quickly and cost-effectively. Initial projects are focused on cancer research, though other indications will be added in due course.